Sight Sciences (SGHT)
Sight Sciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
1.2M
Short interest
settlement 2026-10-15
3.5
Days to cover
-0.6 days vs prior
46.7%
Short share of volume
2026-11-03
9
Fails to deliver
settlement 2026-09-04
Thu 5 Nov
Next earnings
estimated date
-$653K
Insider flow, 90 days
0 buys, 5 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in SGHT is 1,241,141 shares, down 11,631 shares over the last month. Over the last 48 readings it ranged from 726,624 shares (30 June 2026) to 1,913,578 shares (14 March 2025). At the reported average volume of 353K shares a day that is 3.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/sght" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 1,241,141 | -12.4% | 352,869 | 3.52 |
| 2026-09-30 | 1,416,320 | +13.1% | 343,089 | 4.13 |
| 2026-09-15 | 1,252,772 | +2.4% | 147,393 | 8.50 |
| 2026-08-31 | 1,223,511 | +38.5% | 222,551 | 5.50 |
| 2026-08-14 | 883,649 | +6.9% | 415,908 | 2.12 |
| 2026-07-31 | 826,710 | -0.4% | 149,548 | 5.53 |
| 2026-07-15 | 829,847 | +14.2% | 164,994 | 5.03 |
| 2026-06-30 | 726,624 | -9.7% | 256,664 | 2.83 |
| 2026-06-15 | 804,628 | -9.9% | 124,943 | 6.44 |
| 2026-05-29 | 892,961 | +3.5% | 162,035 | 5.51 |
| 2026-05-15 | 862,599 | -7.9% | 244,618 | 3.53 |
| 2026-04-30 | 936,889 | -12.8% | 452,252 | 2.07 |
| 2026-04-15 | 1,074,555 | +0.8% | 190,242 | 5.65 |
| 2026-03-31 | 1,065,987 | -2.8% | 322,135 | 3.31 |
| 2026-03-13 | 1,096,239 | +10.3% | 568,796 | 1.93 |
| 2026-02-27 | 994,015 | -6.7% | 204,050 | 4.87 |
| 2026-02-13 | 1,065,764 | -1.8% | 213,612 | 4.99 |
| 2026-01-30 | 1,085,573 | -6.4% | 271,309 | 4.00 |
| 2026-01-15 | 1,160,035 | +18.0% | 291,476 | 3.98 |
| 2025-12-31 | 983,257 | +15.8% | 370,440 | 2.65 |
| 2025-12-15 | 848,829 | -10.6% | 180,018 | 4.72 |
| 2025-11-28 | 949,316 | +4.9% | 208,556 | 4.55 |
| 2025-11-14 | 905,132 | -6.2% | 306,176 | 2.96 |
| 2025-10-31 | 964,760 | -3.2% | 290,558 | 3.32 |
| 2025-10-15 | 996,196 | -4.3% | 105,567 | 9.44 |
| 2025-09-30 | 1,040,480 | -6.4% | 93,008 | 11.19 |
| 2025-09-15 | 1,112,051 | +6.6% | 111,073 | 10.01 |
| 2025-08-29 | 1,043,629 | -8.7% | 103,854 | 10.05 |
| 2025-08-15 | 1,142,787 | +6.0% | 144,579 | 7.90 |
| 2025-07-31 | 1,078,637 | -2.6% | 101,241 | 10.65 |
| 2025-07-15 | 1,107,427 | -9.8% | 141,247 | 7.84 |
| 2025-06-30 | 1,228,075 | +7.1% | 190,105 | 6.46 |
| 2025-06-13 | 1,147,022 | -4.9% | 164,824 | 6.96 |
| 2025-05-30 | 1,205,992 | -6.2% | 159,209 | 7.57 |
| 2025-05-15 | 1,285,820 | -3.1% | 197,019 | 6.53 |
| 2025-04-30 | 1,327,283 | -10.4% | 173,020 | 7.67 |
| 2025-04-15 | 1,481,157 | -13.5% | 217,143 | 6.82 |
| 2025-03-31 | 1,711,557 | -10.6% | 170,550 | 10.04 |
| 2025-03-14 | 1,913,578 | +22.6% | 403,481 | 4.74 |
| 2025-02-28 | 1,560,484 | +10.3% | 320,298 | 4.87 |
| 2025-02-14 | 1,414,645 | +18.1% | 185,976 | 7.61 |
| 2025-01-31 | 1,198,146 | +12.1% | 261,590 | 4.58 |
| 2025-01-15 | 1,068,834 | -1.5% | 208,513 | 5.13 |
| 2024-12-31 | 1,084,742 | +2.3% | 219,364 | 4.94 |
| 2024-12-13 | 1,060,498 | +7.7% | 228,766 | 4.64 |
| 2024-11-29 | 984,571 | +0.7% | 211,239 | 4.66 |
| 2024-11-15 | 977,459 | -13.0% | 331,268 | 2.95 |
| 2024-10-31 | 1,123,073 | +0.7% | 158,357 | 7.09 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of SGHT volume is 46.7%, up 19.3 points over the last five sessions. Over the last 30 readings it ranged from 27.4% (27 October 2026) to 64.5% (8 October 2026). The latest reading is 2.4 points above the 30-session average of 44.3%, on 130K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 61K | 130K | 46.7% | 18 |
| 2026-11-02 | 24K | 89K | 27.5% | 0 |
| 2026-10-30 | 44K | 108K | 41.1% | 0 |
| 2026-10-29 | 51K | 153K | 33.2% | 0 |
| 2026-10-28 | 46K | 145K | 31.8% | 0 |
| 2026-10-27 | 25K | 93K | 27.4% | 0 |
| 2026-10-26 | 50K | 118K | 42.5% | 1,217 |
| 2026-10-23 | 68K | 126K | 53.8% | 55 |
| 2026-10-22 | 51K | 93K | 54.6% | 0 |
| 2026-10-21 | 24K | 50K | 49.0% | 0 |
| 2026-10-20 | 42K | 113K | 37.4% | 0 |
| 2026-10-19 | 21K | 54K | 40.1% | 0 |
| 2026-10-16 | 38K | 76K | 49.3% | 0 |
| 2026-10-15 | 50K | 95K | 52.6% | 0 |
| 2026-10-14 | 37K | 102K | 36.3% | 0 |
| 2026-10-13 | 49K | 112K | 43.3% | 733 |
| 2026-10-12 | 48K | 142K | 34.1% | 0 |
| 2026-10-09 | 54K | 113K | 47.2% | 0 |
| 2026-10-08 | 68K | 105K | 64.5% | 0 |
| 2026-10-07 | 35K | 74K | 47.8% | 0 |
| 2026-10-06 | 55K | 90K | 61.3% | 50 |
| 2026-10-05 | 79K | 199K | 39.8% | 375 |
| 2026-10-02 | 65K | 145K | 44.7% | 0 |
| 2026-10-01 | 38K | 118K | 32.5% | 0 |
| 2026-09-30 | 59K | 136K | 43.7% | 0 |
| 2026-09-29 | 144K | 280K | 51.6% | 0 |
| 2026-09-28 | 87K | 205K | 42.3% | 330 |
| 2026-09-25 | 39K | 122K | 31.8% | 0 |
| 2026-09-24 | 119K | 199K | 59.9% | 0 |
| 2026-09-23 | 48K | 76K | 62.7% | 1 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 4 September 2026, the fails-to-deliver balance in SGHT is 9 shares, down 5,211 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (13 January 2026) to 21,472 shares (13 February 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-04 | 9 | $8.38 | $75 |
| 2026-08-05 | 5,220 | $5.64 | $29K |
| 2026-08-04 | 2,210 | $5.53 | $12K |
| 2026-07-15 | 539 | $5.05 | $3K |
| 2026-06-26 | 13 | $5.46 | $71 |
| 2026-06-22 | 1,282 | $5.28 | $7K |
| 2026-06-10 | 12 | $4.85 | $58 |
| 2026-06-09 | 1,296 | $4.63 | $6K |
| 2026-06-03 | 4,310 | $4.34 | $19K |
| 2026-05-08 | 31 | $5.29 | $164 |
| 2026-04-21 | 12 | $4.36 | $52 |
| 2026-04-14 | 431 | $3.69 | $2K |
| 2026-04-06 | 629 | $3.52 | $2K |
| 2026-02-24 | 27 | $5.36 | $145 |
| 2026-02-13 | 21,472 | $5.39 | $116K |
| 2026-01-21 | 220 | $6.24 | $1K |
| 2026-01-13 | 8 | $7.41 | $59 |
| 2026-01-05 | 523 | $7.48 | $4K |
| 2025-11-25 | 583 | $7.49 | $4K |
| 2025-10-14 | 3,226 | $3.26 | $11K |
| 2025-09-03 | 148 | $3.87 | $573 |
| 2025-08-27 | 255 | $4.23 | $1K |
| 2025-07-10 | 2,722 | $3.52 | $10K |
| 2025-07-08 | 8,619 | $3.48 | $30K |
| 2025-07-03 | 1,000 | $4.16 | $4K |
| 2025-06-24 | 2,677 | $4.34 | $12K |
| 2025-06-13 | 135 | $4.21 | $568 |
| 2025-06-12 | 200 | $4.19 | $838 |
| 2025-06-09 | 447 | $4.20 | $2K |
| 2025-05-15 | 41 | $3.28 | $134 |
Insider trades
SEC Form 4, newest first. JSONInsiders at SGHT reported 5 open-market sells worth $653K in the last 90 days and no open-market buys. Latest filing: Taylor Brenton (EVP, Operations & R&D) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton | EVP, Operations & R&D | Sell | 3K | $8.85 | $26K | 262K |
| 2026-10-02 | Rodberg James | Chief Financial Officer | Sell | 7K | $8.85 | $64K | 217K |
| 2026-10-02 | Bauerlein Alison | Chief Operating Officer | Sell | 25K | $8.85 | $224K | 639K |
| 2026-10-01 | Badawi Paul | President and CEO | Sell | 30K | $9.05 | $268K | 6.1M |
| 2026-10-01 | Badawi David | Chief Technology Officer | Sell | 8K | $9.05 | $71K | 2.0M |
| 2026-08-10 | Rashid Kashif | Chief Legal Officer | Grant | 182K | $0.00 | $0 | 182K |
| 2026-07-06 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 13K | $5.51 | $70K | 357K |
| 2026-07-06 | Badawi David | Chief Technology Officer | Sell | 7K | $5.51 | $41K | 2.0M |
| 2026-07-02 | Rodberg James | Chief Financial Officer | Sell | 7K | $5.36 | $37K | 224K |
| 2026-07-02 | Bauerlein Alison | Chief Operating Officer | Sell | 24K | $5.36 | $130K | 665K |
| 2026-07-01 | Taylor Brenton | EVP, Operations & R&D | Sell | 3K | $5.42 | $15K | 265K |
| 2026-07-01 | Badawi Paul | President and CEO | Sell | 29K | $5.42 | $155K | 6.1M |
| 2026-06-10 | Encrantz Staffan | Director, 10% owner | Buy | 14K | $4.88 | $69K | 1.4M |
| 2026-06-04 | Zurbay Donald | Director | Grant | 28K | $0.00 | $0 | 194K |
| 2026-06-04 | Mazzacco Catherine | Director | Grant | 28K | $0.00 | $0 | 69K |
| 2026-06-04 | Fountain Tamara | Director | Grant | 28K | $0.00 | $0 | 110K |
| 2026-06-04 | Encrantz Staffan | Director, 10% owner | Grant | 28K | $0.00 | $0 | 1.4M |
| 2026-06-04 | Burbach Gerhard F | Director | Grant | 28K | $0.00 | $0 | 123K |
| 2026-05-18 | Bauerlein Alison | Chief Operating Officer | Sell | 13K | $5.12 | $65K | 689K |
| 2026-04-06 | Rodberg James | Chief Financial Officer | Sell | 7K | $3.55 | $26K | 231K |
| 2026-04-06 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 14K | $3.55 | $49K | 370K |
| 2026-04-02 | Bauerlein Alison | Chief Operating Officer | Sell | 26K | $3.48 | $90K | 702K |
| 2026-04-02 | Badawi David | Chief Technology Officer | Sell | 8K | $3.48 | $28K | 2.0M |
| 2026-04-01 | Taylor Brenton | EVP, Operations & R&D | Sell | 3K | $3.70 | $11K | 268K |
| 2026-04-01 | Badawi Paul | President and CEO | Sell | 29K | $3.70 | $108K | 6.2M |
| 2026-02-19 | Badawi David | Chief Technology Officer | Exercise or conversion | 21K | $0.23 | $5K | 2.0M |
| 2026-02-03 | Taylor Brenton | EVP, Operations & R&D | Grant | 100K | $0.00 | $0 | 271K |
| 2026-02-03 | Rodberg James | Chief Financial Officer | Grant | 87K | $0.00 | $0 | 238K |
| 2026-02-03 | HAYDEN JEREMY B. | Chief Legal Officer | Grant | 116K | $0.00 | $0 | 384K |
| 2026-02-03 | Bauerlein Alison | Chief Operating Officer | Grant | 128K | $0.00 | $0 | 727K |
| 2026-02-03 | Badawi Paul | President and CEO | Grant | 155K | $0.00 | $0 | 6.2M |
| 2026-02-03 | Badawi David | Chief Technology Officer | Grant | 65K | $0.00 | $0 | 2.0M |
| 2026-01-16 | Rodberg James | Chief Financial Officer | Sell | 3K | $6.62 | $17K | 151K |
| 2026-01-16 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 6K | $6.62 | $42K | 268K |
| 2026-01-16 | Badawi Paul | President and CEO | Sell | 22K | $6.62 | $148K | 6.0M |
| 2026-01-16 | Badawi David | Chief Technology Officer | Sell | 5K | $6.62 | $32K | 1.9M |
| 2026-01-06 | Taylor Brenton | EVP, Operations & R&D | Sell | 619 | $7.48 | $5K | 170K |
| 2026-01-06 | Rodberg James | Chief Financial Officer | Sell | 594 | $7.48 | $4K | 154K |
| 2026-01-06 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 2K | $7.48 | $13K | 245K |
| 2026-01-06 | Bauerlein Alison | Chief Operating Officer | Sell | 10K | $7.48 | $72K | 600K |
| 2026-01-06 | Badawi Paul | President and CEO | Sell | 12K | $7.48 | $89K | 5.9M |
| 2026-01-06 | Badawi David | Chief Technology Officer | Sell | 4K | $7.48 | $28K | 1.9M |
| 2026-01-05 | Rodberg James | Chief Financial Officer | Sell | 4K | $7.82 | $34K | 154K |
| 2026-01-05 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9K | $7.82 | $73K | 247K |
| 2026-01-05 | Bauerlein Alison | Chief Operating Officer | Sell | 11K | $7.82 | $85K | 610K |
| 2026-01-05 | Badawi David | Chief Technology Officer | Sell | 3K | $7.82 | $24K | 1.9M |
| 2026-01-02 | Badawi Paul | President and CEO | Sell | 25K | $7.43 | $188K | 5.9M |
| 2026-01-02 | Badawi David | Chief Technology Officer | Sell | 3K | $7.43 | $22K | 1.9M |
| 2025-12-26 | Badawi David | Chief Technology Officer | Exercise or conversion | 21K | $0.23 | $5K | 1.9M |
| 2025-12-16 | Encrantz Staffan | Director, 10% owner | Buy | 14K | $8.31 | $116K | 1.4M |
| 2025-12-02 | Rodberg James | Chief Financial Officer | Sell | 3K | $8.25 | $21K | 159K |
| 2025-11-25 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 45K | $8.08 | $362K | 257K |
| 2025-11-25 | HAYDEN JEREMY B. | Chief Legal Officer | Exercise or conversion | 7K | $1.96 | $14K | 301K |
| 2025-11-25 | HAYDEN JEREMY B. | Chief Legal Officer | Exercise or conversion | 38K | $1.96 | $74K | 294K |
| 2025-11-17 | Taylor Brenton | EVP, Operations & R&D | Sell | 14K | $7.06 | $102K | 171K |
| 2025-11-12 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 3K | $8.01 | $25K | 257K |
| 2025-11-12 | HAYDEN JEREMY B. | Chief Legal Officer | Exercise or conversion | 710 | $1.96 | $1K | 260K |
| 2025-11-12 | HAYDEN JEREMY B. | Chief Legal Officer | Exercise or conversion | 2K | $1.96 | $5K | 259K |
| 2025-11-11 | Rodberg James | Chief Financial Officer | Grant | 15K | $0.00 | $0 | 161K |
| 2025-11-11 | Bauerlein Alison | Chief Operating Officer | Grant | 23K | $0.00 | $0 | 621K |
| 2025-10-06 | Taylor Brenton | EVP, Operations & R&D | Sell | 591 | $3.37 | $2K | 185K |
| 2025-10-03 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 10K | $3.27 | $32K | 257K |
| 2025-10-03 | Badawi David | Chief Technology Officer | Sell | 6K | $3.27 | $20K | 1.9M |
| 2025-10-02 | Bauerlein Alison | Chief Financial Officer | Sell | 20K | $3.30 | $66K | 598K |
| 2025-10-01 | Badawi Paul | President and CEO | Sell | 24K | $3.34 | $82K | 6.0M |
| 2025-09-11 | Mazzacco Catherine | Director | Gift | 37K | $0.00 | $0 | 41K |
| 2025-09-02 | Taylor Brenton | EVP, Operations & R&D | Grant | 26K | $0.00 | $0 | 186K |
| 2025-07-17 | Badawi David | Chief Technology Officer | Exercise or conversion | 40K | $0.12 | $5K | 1.9M |
| 2025-07-03 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9K | $4.17 | $38K | 266K |
| 2025-07-03 | Badawi David | Chief Technology Officer | Sell | 6K | $4.17 | $24K | 1.8M |
| 2025-07-02 | Link Matthew | Chief Commercial Officer | Sell | 5K | $4.10 | $20K | 832K |
| 2025-07-02 | Bauerlein Alison | Chief Financial Officer | Sell | 19K | $4.10 | $79K | 617K |
| 2025-07-01 | Badawi Paul | President and CEO | Sell | 24K | $4.15 | $98K | 6.0M |
| 2025-06-06 | Encrantz Staffan | Director,TenPercentOwner | Buy | 28K | $4.22 | $118K | 1.4M |
| 2025-06-05 | Encrantz Staffan | Director,TenPercentOwner | Buy | 41K | $4.24 | $174K | 1.3M |
| 2025-06-05 | Encrantz Staffan | Director,TenPercentOwner | Grant | 31K | $0.00 | $0 | 1.4M |
| 2025-06-05 | Zurbay Donald | Director | Grant | 31K | $0.00 | $0 | 165K |
| 2025-06-05 | Fountain Tamara | Director | Grant | 31K | $0.00 | $0 | 81K |
| 2025-06-05 | Rogers Erica J. | Director | Grant | 31K | $0.00 | $0 | 175K |
| 2025-06-05 | Larsen-Becker Brenda Jane | Director | Grant | 31K | $0.00 | $0 | 79K |
| 2025-06-05 | Mazzacco Catherine | Director | Grant | 31K | $0.00 | $0 | 79K |
| 2025-06-04 | Encrantz Staffan | Director,TenPercentOwner | Buy | 22K | $4.17 | $90K | 1.3M |
| 2025-06-03 | Encrantz Staffan | Director,TenPercentOwner | Buy | 25K | $3.97 | $100K | 1.3M |
| 2025-06-02 | Encrantz Staffan | Director,TenPercentOwner | Buy | 31K | $3.88 | $120K | 1.2M |
| 2025-05-30 | Encrantz Staffan | Director,TenPercentOwner | Buy | 43K | $3.67 | $157K | 1.2M |
| 2025-05-29 | Encrantz Staffan | Director,TenPercentOwner | Buy | 60K | $3.59 | $216K | 1.2M |
| 2025-05-28 | Encrantz Staffan | Director,TenPercentOwner | Buy | 27K | $3.52 | $94K | 1.1M |
| 2025-05-27 | Encrantz Staffan | Director,TenPercentOwner | Buy | 41K | $3.44 | $142K | 1.1M |
| 2025-05-19 | Bauerlein Alison | Chief Financial Officer | Sell | 13K | $3.48 | $45K | 637K |
| 2025-05-16 | Link Matthew | Chief Commercial Officer | Grant | 7K | $3.02 | $20K | 837K |
| 2025-05-16 | Raheja Manohar K. | EVP, Research & Development | Grant | 13K | $3.02 | $39K | 168K |
| 2025-05-12 | Burbach Gerhard F | Director | Grant | 75K | $0.00 | $0 | 95K |
| 2025-04-02 | Bauerlein Alison | Chief Financial Officer | Sell | 19K | $2.31 | $45K | 650K |
| 2025-04-02 | Link Matthew | Chief Commercial Officer | Sell | 5K | $2.31 | $12K | 831K |
| 2025-04-02 | HAYDEN JEREMY B. | Chief Legal Officer | Sell | 9K | $2.31 | $22K | 275K |
| 2025-04-01 | Badawi David | Chief Technology Officer | Sell | 6K | $2.30 | $14K | 1.8M |
| 2025-04-01 | Badawi Paul | President and CEO | Sell | 24K | $2.30 | $56K | 6.0M |
| 2025-03-13 | Raheja Manohar K. | EVP, Research & Development | Buy | 10K | $2.60 | $26K | 155K |
| 2025-03-12 | Encrantz Staffan | Director,TenPercentOwner | Other transaction | 243K | $2.77 | $673K | 5.1M |
| 2025-03-12 | Raheja Manohar K. | EVP, Research & Development | Buy | 10K | $2.73 | $27K | 145K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for SGHT worth $4.3M at the prices reported; 14 in the last 90 days worth $1.9M. Latest: Rodberg James filed on 2026-10-02 to sell 7,208 shares ($64K) from 2026-10-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-02 | Rodberg JamesOfficer | 7K | $64K | 0.013% | 2026-10-02 | Fidelity Brokerage Services LLC |
| 2026-10-02 | Bauerlein AlisonOfficer | 25K | $224K | 0.046% | 2026-10-02 | Fidelity Brokerage Services LLC |
| 2026-10-02 | Taylor BrentonOfficer | 3K | $26K | 0.005% | 2026-10-02 | Fidelity Brokerage Services LLC |
| 2026-10-01 | Badawi DavidOfficer, Director | 8K | $71K | 0.014% | 2026-10-01 | Fidelity Brokerage Services LLC |
| 2026-10-01 | Badawi PaulOfficer, Director | 30K | $268K | 0.054% | 2026-10-01 | Fidelity Brokerage Services LLC |
| 2026-10-01 | HAYDEN JEREMY B.Former Officer | 3K | $25K | 0.005% | 2026-10-01 | Fidelity Brokerage Services LLC |
| 2026-09-30 | HAYDEN JEREMY B.Former Officer | 22K | $208K | 0.040% | 2026-09-30 | Fidelity Brokerage Services LLC |
| 2026-09-04 | HAYDEN JEREMY B.Former Officer | 12K | $101K | 0.022% | 2026-09-04 | Fidelity Brokerage Services LLC |
| 2026-09-01 | HAYDEN JEREMY B.Former Officer | 13K | $110K | 0.024% | 2026-09-01 | Fidelity Brokerage Services LLC |
| 2026-08-17 | HAYDEN JEREMY B.Former Officer | 12K | $98K | 0.022% | 2026-08-17 | Fidelity Brokerage Services LLC |
| 2026-08-14 | HAYDEN JEREMY B.Former Officer | 48K | $396K | 0.087% | 2026-08-14 | Fidelity Brokerage Services LLC |
| 2026-08-13 | HAYDEN JEREMY B.Former Officer | 3K | $21K | 0.005% | 2026-08-13 | Fidelity Brokerage Services LLC |
| 2026-08-12 | HAYDEN JEREMY B.Former Officer | 16K | $133K | 0.030% | 2026-08-12 | Fidelity Brokerage Services LLC |
| 2026-08-11 | HAYDEN JEREMY B.Officer | 21K | $166K | 0.038% | 2026-08-11 | Fidelity Brokerage Services LLC |
| 2026-07-06 | HAYDEN JEREMY B.Officer | 13K | $70K | 0.023% | 2026-07-06 | Fidelity Brokerage Services LLC |
| 2026-07-06 | Badawi DavidOfficer, Director | 7K | $41K | 0.014% | 2026-07-06 | Fidelity Brokerage Services LLC |
| 2026-07-02 | Rodberg JamesOfficer | 7K | $37K | 0.013% | 2026-07-02 | Fidelity Brokerage Services LLC |
| 2026-07-02 | Bauerlein AlisonOfficer | 24K | $130K | 0.044% | 2026-07-02 | Fidelity Brokerage Services LLC |
| 2026-07-01 | Taylor BrentonOfficer | 3K | $15K | 0.005% | 2026-07-01 | Fidelity Brokerage Services LLC |
| 2026-07-01 | Badawi PaulOfficer, Director | 29K | $155K | 0.053% | 2026-07-01 | Fidelity Brokerage Services LLC |
| 2026-05-18 | Bauerlein AlisonOfficer | 13K | $65K | 0.023% | 2026-05-18 | Fidelity Brokerage Services LLC |
| 2026-04-06 | Rodberg JamesOfficer | 7K | $26K | 0.013% | 2026-04-06 | Fidelity Brokerage Services LLC |
| 2026-04-06 | HAYDEN JEREMY B.Officer | 14K | $49K | 0.025% | 2026-04-06 | Fidelity Brokerage Services LLC |
| 2026-04-02 | Bauerlein AlisonOfficer | 26K | $90K | 0.048% | 2026-04-02 | Fidelity Brokerage Services LLC |
| 2026-04-02 | Badawi DavidOfficer, Director | 8K | $28K | 0.015% | 2026-04-02 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Taylor BrentonOfficer | 3K | $11K | 0.005% | 2026-04-01 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Badawi PaulOfficer, Director | 29K | $108K | 0.054% | 2026-04-01 | Fidelity Brokerage Services LLC |
| 2026-01-16 | Rogers Erica J.Former Director | 10K | $64K | 0.018% | 2026-01-16 | Fidelity Brokerage Services LLC |
| 2026-01-16 | Rodberg JamesOfficer | 3K | $17K | 0.005% | 2026-01-16 | Fidelity Brokerage Services LLC |
| 2026-01-16 | HAYDEN JEREMY B.Officer | 6K | $42K | 0.012% | 2026-01-16 | Fidelity Brokerage Services LLC |
| 2026-01-16 | Badawi PaulOfficer, Director | 22K | $148K | 0.042% | 2026-01-16 | Fidelity Brokerage Services LLC |
| 2026-01-16 | Badawi DavidOfficer, Director | 5K | $32K | 0.009% | 2026-01-16 | Fidelity Brokerage Services LLC |
| 2026-01-15 | Rogers Erica J.Former Director | 20K | $132K | 0.038% | 2026-01-15 | Fidelity Brokerage Services LLC |
| 2026-01-12 | Rogers Erica J.Former Director | 10K | $74K | 0.019% | 2026-01-12 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Taylor BrentonOfficer | 619 | $5K | 0.001% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Rodberg JamesOfficer | 594 | $4K | 0.001% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-06 | HAYDEN JEREMY B.Officer | 2K | $13K | 0.003% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Bauerlein AlisonOfficer | 10K | $72K | 0.018% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Badawi PaulOfficer, Director | 12K | $89K | 0.022% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-06 | Badawi DavidOfficer, Director | 4K | $28K | 0.007% | 2026-01-06 | Fidelity Brokerage Services LLC |
| 2026-01-05 | Rodberg JamesOfficer | 4K | $34K | 0.008% | 2026-01-05 | Fidelity Brokerage Services LLC |
| 2026-01-05 | HAYDEN JEREMY B.Officer | 9K | $73K | 0.018% | 2026-01-05 | Fidelity Brokerage Services LLC |
| 2026-01-05 | Bauerlein AlisonOfficer | 11K | $85K | 0.021% | 2026-01-05 | Fidelity Brokerage Services LLC |
| 2026-01-05 | Badawi DavidOfficer, Director | 3K | $24K | 0.006% | 2026-01-05 | Fidelity Brokerage Services LLC |
| 2026-01-02 | Badawi PaulOfficer, Director | 25K | $188K | 0.048% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2026-01-02 | Badawi DavidOfficer, Director | 3K | $22K | 0.006% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2025-12-30 | Rogers Erica J.Former Director | 10K | $84K | 0.019% | 2025-12-30 | Fidelity Brokerage Services LLC |
| 2025-12-29 | Rogers Erica J.Former Director | 20K | $173K | 0.038% | 2025-12-29 | Fidelity Brokerage Services LLC |
| 2025-12-02 | Rodberg JamesOfficer | 3K | $21K | 0.005% | 2025-12-02 | Fidelity Brokerage Services LLC |
| 2025-11-26 | Link MatthewFormer Officer | 13K | $98K | 0.024% | 2025-11-26 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of SGHT in its latest filing, on Schedule 13G (passive). The holder is BlackRock, Inc. at 5.0% of the class (2,651,156 shares), filed 2026-01-21 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-08 | 13G/Ano. 4 | KCK LTD.other entity | 1.4M | 2.7% | 2026-03-31 |
| 2026-04-08 | 13G/Ano. 4 | Nael Karim Kassarindividual | 1.4M | 2.7% | 2026-03-31 |
| 2026-01-21 | 13G | BlackRock, Inc.parent holding company | 2.7M | 5.0% | 2025-12-31 |
13F holders
Tracked managers holding SGHT at their latest 13F. JSON7 of the 30 tracked managers held SGHT at their latest 13F, $6.7M in total at quarter-end prices. AQR Capital Management is the largest at $2.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 398K | $2.2M | 0.00% | +259K |
| D. E. Shaw & Co. | 2026-06-30 | 280K | $1.5M | 0.00% | -31K |
| Citadel Advisors | 2026-06-30 | 216K | $1.2M | 0.00% | +81K |
| Renaissance Technologies | 2026-06-30 | 213K | $1.2M | 0.00% | -81K |
| Millennium Management | 2026-06-30 | 75K | $408K | 0.00% | -185K |
| Two Sigma Investments | 2026-06-30 | 41K | $222K | 0.00% | -86K |
| Point72 Asset Management | 2026-06-30 | 16K | $87K | 0.00% | -83K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Sight Sciences reported revenue of $23.4M, up 19.5% from the same quarter a year earlier, and net loss of $4.4M (-0.08 diluted EPS). In FY 2025 it generated -$29.7M of operating cash flow. As of 2026-06-30, cash was $79.8M against $30.6M of debt.
- Cash
- $79.8M
- Debt
- $30.6M
- Equity
- $52.9M
- Total assets
- $104.9M
- Shares outstanding
- 55,087,990
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $23.4M | -$4.4M | -19.0% | -0.08 |
| Q1 FY 2026 | 2026-03-31 | $19.7M | -$13.0M | -65.9% | -0.24 |
| Q4 FY 2025derived | 2025-12-31 | $20.4M | -$4.2M | -20.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $19.9M | -$8.2M | -41.0% | -0.16 |
| Q2 FY 2025 | 2025-06-30 | $19.6M | -$11.9M | -61.0% | -0.23 |
| Q1 FY 2025 | 2025-03-31 | $17.5M | -$14.2M | -80.8% | -0.28 |
| Q4 FY 2024derived | 2024-12-31 | $19.1M | -$11.8M | -62.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $20.2M | -$11.1M | -54.9% | -0.22 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $77.4M | -$38.4M | -$29.7M | $224K | n/a | n/a |
| FY 2024 | 2024-12-31 | $79.9M | -$51.5M | -$22.4M | $385K | n/a | n/a |
| FY 2023 | 2023-12-31 | $81.1M | -$55.5M | -$47.2M | $791K | n/a | n/a |
| FY 2022 | 2022-12-31 | $71.3M | -$86.2M | -$76.0M | $970K | n/a | n/a |
| FY 2021 | 2021-12-31 | $49.0M | -$63.0M | -$52.5M | $813K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Sight Sciences in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Sight Sciences (SGHT), SEC CIK 1531177, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-04.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-08.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1531177Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of SGHT is sold short?
1,241,141 shares were held short at the 2026-10-15 settlement, 3.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is SGHT's daily short volume?
On 2026-11-03, 60,605 of the 129,775 SGHT shares reported to FINRA were sold short, 46.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does SGHT have fails to deliver?
The SEC's latest file shows 9 SGHT shares failed to deliver at settlement 2026-09-04. Fails are reported per settlement date and published twice a month with a lag.
Are SGHT insiders buying or selling?
Insiders at SGHT reported 5 open-market sells worth $653K in the last 90 days and no open-market buys. Latest filing: Taylor Brenton (EVP, Operations & R&D) on 2026-10-02.
Have SGHT insiders filed to sell?
50 Form 144 notices on file for SGHT worth $4.3M at the prices reported; 14 in the last 90 days worth $1.9M. Latest: Rodberg James filed on 2026-10-02 to sell 7,208 shares ($64K) from 2026-10-02.
Who owns 5% or more of SGHT?
1 holder reports 5% or more of SGHT in its latest filing, on Schedule 13G (passive). The holder is BlackRock, Inc. at 5.0% of the class (2,651,156 shares), filed 2026-01-21 for an event on 2025-12-31.
What did SGHT report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Sight Sciences reported revenue of $23.4M, up 19.5% from the same quarter a year earlier, and net loss of $4.4M (-0.08 diluted EPS). In FY 2025 it generated -$29.7M of operating cash flow. As of 2026-06-30, cash was $79.8M against $30.6M of debt.
Which tracked 13F managers own SGHT?
7 of the 30 tracked 13F managers held SGHT shares at their latest filing, $6.7M in all. The largest: Cliff Asness's AQR Capital Management (398K shares, $2.2M), D. E. Shaw & Co. (280K shares, $1.5M), Ken Griffin's Citadel Advisors (216K shares, $1.2M), Renaissance Technologies (213K shares, $1.2M), Izzy Englander's Millennium Management (75K shares, $408K), Two Sigma Investments (41K shares, $222K). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.